Podcast: Download (Duration: 1:03 — 1.4MB)
Subscribe: RSS
Implantable recorders, which are placed under the skin and monitor someone’s heart for a prolonged period of time, may help identify a heart condition known as atrial fibrillation in those who’ve had a stroke, two recent studies find. Michele Johansen, …
Podcast: Download (Duration: 1:06 — 1.5MB)
Subscribe: RSS
Medicare is poised to spend millions of dollars on aducanumab, a just approved drug for Alzheimer’s disease the FDA’s own advisory panel recommended against approving. Caleb Alexander, a member of the panel and an internal medicine expert at Johns Hopkins, …
Podcast: Download (Duration: 1:03 — 1.5MB)
Subscribe: RSS
Is amyloid, a substance that accumulates in the brains of people with Alzheimer’s disease, the cause of the disease or simply a bystander? No one knows, and that’s why an FDA advisory panel voted against approving a new drug to …
Why is a new Alzheimer’s drug so controversial? Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:02 — 1.4MB)
Subscribe: RSS
The amyloid hypothesis. That’s the idea that accumulation of a material called amyloid in the brain leads to Alzheimer’s disease. Acceptance of this idea has led the FDA to approve aducanumab, which reduces amyloid, but isn’t known to improve any …
Podcast: Download (Duration: 1:03 — 1.5MB)
Subscribe: RSS
Aducanumab or Aduhelm is a newly approved medicine for treating Alzheimer’s disease, with many experts asserting that it should never have gotten FDA approval. Caleb Alexander, an internal medicine expert at Johns Hopkins and a member of the FDA review …
